1048 related items for PubMed ID: 25248580
1. Corticotropin-releasing hormone and the hypothalamic-pituitary-adrenal axis in psychiatric disease.
Naughton M, Dinan TG, Scott LV.
Handb Clin Neurol; 2014; 124():69-91. PubMed ID: 25248580
[Abstract] [Full Text] [Related]
2. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
Scott LV, Dinan TG.
Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097
[Abstract] [Full Text] [Related]
3. Relationships between psychological distress, coping styles, and HPA axis reactivity in healthy adults.
Hori H, Ozeki Y, Teraishi T, Matsuo J, Kawamoto Y, Kinoshita Y, Suto S, Terada S, Higuchi T, Kunugi H.
J Psychiatr Res; 2010 Oct; 44(14):865-73. PubMed ID: 20334880
[Abstract] [Full Text] [Related]
4. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.
Cai L, Li R, Tang WJ, Meng G, Hu XY, Wu TN.
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157
[Abstract] [Full Text] [Related]
5. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior.
Sher L.
ScientificWorldJournal; 2006 Oct 31; 6():1398-404. PubMed ID: 17086345
[Abstract] [Full Text] [Related]
6. Corticotropin-releasing hormone and arginine vasopressin in depression focus on the human postmortem hypothalamus.
Bao AM, Swaab DF.
Vitam Horm; 2010 Oct 31; 82():339-65. PubMed ID: 20472147
[Abstract] [Full Text] [Related]
7. How to measure glucocorticoid receptor's sensitivity in patients with stress-related psychiatric disorders.
Leistner C, Menke A.
Psychoneuroendocrinology; 2018 May 31; 91():235-260. PubMed ID: 29449045
[Abstract] [Full Text] [Related]
8. Mice selected for extremes in stress reactivity reveal key endophenotypes of major depression: a translational approach.
Heinzmann JM, Kloiber S, Ebling-Mattos G, Bielohuby M, Schmidt MV, Palme R, Holsboer F, Uhr M, Ising M, Touma C.
Psychoneuroendocrinology; 2014 Nov 31; 49():229-43. PubMed ID: 25123105
[Abstract] [Full Text] [Related]
9. The hypothalamic-pituitary-adrenal axis in borderline personality disorder: a review.
Zimmerman DJ, Choi-Kain LW.
Harv Rev Psychiatry; 2009 Nov 31; 17(3):167-83. PubMed ID: 19499417
[Abstract] [Full Text] [Related]
10. Long-term effects of early adolescent stress: dysregulation of hypothalamic-pituitary-adrenal axis and central corticotropin releasing factor receptor 1 expression in adult male rats.
Li C, Liu Y, Yin S, Lu C, Liu D, Jiang H, Pan F.
Behav Brain Res; 2015 Jul 15; 288():39-49. PubMed ID: 25882722
[Abstract] [Full Text] [Related]
11. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
Tajima-Pozo K, Montes-Montero A, Güemes I, González-Vives S, Díaz-Marsá M, Carrasco JL.
Endocrinol Nutr; 2013 Jul 15; 60(7):396-403. PubMed ID: 23623464
[Abstract] [Full Text] [Related]
12. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M.
Neuropsychopharmacology; 2006 Jan 15; 31(1):212-20. PubMed ID: 16123748
[Abstract] [Full Text] [Related]
13. Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus.
Flandreau EI, Ressler KJ, Owens MJ, Nemeroff CB.
Psychoneuroendocrinology; 2012 Jan 15; 37(1):27-38. PubMed ID: 21616602
[Abstract] [Full Text] [Related]
14. Role of noradrenergic projections to the bed nucleus of the stria terminalis in the regulation of the hypothalamic-pituitary-adrenal axis.
Forray MI, Gysling K.
Brain Res Brain Res Rev; 2004 Dec 15; 47(1-3):145-60. PubMed ID: 15572169
[Abstract] [Full Text] [Related]
15. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
Vining C, Iyer V, Bhatnagar S.
J Neuroendocrinol; 2007 Mar 15; 19(3):198-207. PubMed ID: 17280593
[Abstract] [Full Text] [Related]
16. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
Psychoneuroendocrinology; 2008 Feb 15; 33(2):152-61. PubMed ID: 18068306
[Abstract] [Full Text] [Related]
17. Stress responsive neurohormones in depression and anxiety.
Ströhle A, Holsboer F.
Pharmacopsychiatry; 2003 Nov 15; 36 Suppl 3():S207-14. PubMed ID: 14677081
[Abstract] [Full Text] [Related]
18. The stress system in the human brain in depression and neurodegeneration.
Swaab DF, Bao AM, Lucassen PJ.
Ageing Res Rev; 2005 May 15; 4(2):141-94. PubMed ID: 15996533
[Abstract] [Full Text] [Related]
19. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC.
J Psychiatr Res; 2007 May 15; 41(1-2):131-43. PubMed ID: 16455105
[Abstract] [Full Text] [Related]
20. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review.
Juruena MF, Bocharova M, Agustini B, Young AH.
J Affect Disord; 2018 Jun 15; 233():45-67. PubMed ID: 29150144
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
